ARTICLE | Distillery Therapeutics
Targeting the histone methyltransferase EHMT2 for breast cancer recurrence
December 30, 2020 9:38 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Breast cancer...
BCIQ Company Profiles
BCIQ Target Profiles
Euchromatic histone-lysine N-methyltransferase 2 (EHMT2) (G9A)